Brainomix secures $18M to enhance stroke and lung fibrosis treatment
Brainomix, a company offering AI-powered imaging tools for stroke and lung fibrosis, announced the completion of an $18 million Series C investment round.The round was co-led by existing investors Parkwalk Advisors and the Boehringer…
Continue Reading